Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
21/04/2025

Archive: 21/04/2025

Combining brain stimulation with speech therapy shows promise for restoring language in primary progressive aphasia

Primary progressive aphasia is a neurological condition that causes a gradual decline in language abilities. There is no cure or medication that can reverse or stop the progression of PPA. The standard practice in the clinical ...

Apr 21, 2025

0

8

Using pilocarpine drops post goniotomy may reduce long-term glaucoma medication needs

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new research published by faculty ...

Apr 21, 2025

0

1

Psilocybin use rises across all age groups following 2019 decriminalization

A multisource observational study aimed to quantify the change in prevalence and health care utilization of psilocybin users between 2014 and 2023. The study found that the prevalence of psilocybin use increased across all ...

Apr 21, 2025

0

84

Hormone therapy may improve heart health in menopausal women

Deciding whether to start hormone therapy during the menopause transition, the life phase that's the bookend to puberty and when a woman's menstrual cycle stops, is a hotly debated topic. While hormone therapy—replacing ...

Apr 21, 2025

0

1

Cancer mortality continuing to decline, says report

Overall cancer mortality rates declined from 2001 through 2022, while cancer incidence rates decreased from 2001 through 2013 and stabilized through 2021, according to the 2024 Annual Report to the Nation on the Status of ...

Apr 21, 2025

0

0

Adverse pregnancy outcomes partly mediate association between prepregnancy obesity, cardiovascular disease risk

Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in midlife, according to a study published in the April 22 issue of the Journal ...

Apr 21, 2025

0

0

Unvaccinated kids face up to 20 times higher risk of long COVID, analysis finds

Unvaccinated children and adolescents were up to 20 times more likely to develop long COVID than their vaccinated peers, according to new research led by a team from the Perelman School of Medicine at the University of Pennsylvania. ...

Apr 21, 2025

0

751

Alzheimer's risk factors that can impact cognition in adults as young as 24 revealed

A new study from Columbia University Mailman School of Public Health and the Columbia Butler Aging Center suggests that risk factors and biomarkers related to Alzheimer's disease are associated with cognition much earlier ...

Apr 21, 2025

0

161

Some lung cancer patients may experience durable disease control even after discontinuing immunotherapy

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due to immune-related adverse events (irAEs) continued to experience long-term disease control, according ...

Apr 21, 2025

0

1

Tumor byproduct blocks immune cells from fighting cancer, offering new treatment target

A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, has identified a novel oncometabolite that accumulates in tumors and impairs immune cells' ability ...

Apr 21, 2025

0

43

page 1 from 7

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2025 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us